14:13:42 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2023-11-07 15-10 2023-Q3
2023-08-16 Kvartalsrapport 2023-Q2
2023-05-03 15-10 2023-Q1
2023-03-09 Ordinarie utdelning DEMANT 0.00 DKK
2023-03-08 Årsstämma 2023
2023-02-07 Bokslutskommuniké 2022
2022-11-09 15-10 2022-Q3
2022-08-16 Kvartalsrapport 2022-Q2
2022-05-03 15-10 2022-Q1
2022-03-11 Ordinarie utdelning DEMANT 0.00 DKK
2022-03-10 Årsstämma 2022
2022-02-08 Bokslutskommuniké 2021
2021-08-12 Kvartalsrapport 2021-Q2
2021-03-08 Ordinarie utdelning DEMANT 0.00 DKK
2021-03-05 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-08-17 Kvartalsrapport 2020-Q2
2020-03-11 Ordinarie utdelning DEMANT 0.00 DKK
2020-03-10 Årsstämma 2020
2020-02-04 Bokslutskommuniké 2019
2019-08-14 Kvartalsrapport 2019-Q2
2019-03-20 Ordinarie utdelning DEMANT 0.00 DKK
2019-03-19 Årsstämma 2019
2019-02-19 Bokslutskommuniké 2018
2018-08-15 Kvartalsrapport 2018-Q2
2018-03-23 Ordinarie utdelning DEMANT 0.00 DKK
2018-03-22 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-08-14 Kvartalsrapport 2017-Q2
2017-05-09 Kvartalsrapport 2017-Q1
2017-03-28 Ordinarie utdelning DEMANT 0.00 DKK
2017-03-27 Årsstämma 2017
2017-02-23 Bokslutskommuniké 2016
2016-11-10 Kvartalsrapport 2016-Q3
2016-08-17 Kvartalsrapport 2016-Q2
2016-05-25 Split DEMANT 1:5
2016-05-10 Kvartalsrapport 2016-Q1
2016-04-08 Ordinarie utdelning DEMANT 0.00 DKK
2016-04-07 Årsstämma 2016
2016-03-01 Bokslutskommuniké 2015
2015-11-12 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-07 Kvartalsrapport 2015-Q1
2015-04-10 Ordinarie utdelning DEMANT 0.00 DKK
2015-04-09 Årsstämma 2015
2015-02-26 Bokslutskommuniké 2014
2014-04-10 Ordinarie utdelning DEMANT 0.00 DKK
2013-04-10 Ordinarie utdelning
2012-04-12 Ordinarie utdelning DEMANT 0.00 DKK
2011-04-14 Ordinarie utdelning
2010-04-08 Ordinarie utdelning

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Demant är verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av hörapparater och hörslingor. Idag innehar bolaget verksamhet på global nivå där produkterna säljs under varierande varumärken. Produkterna nås via bolagets distributörer och försäljningskanaler. Utöver huvudverksamheten bedriver bolaget forskning inom diagnostik för mätning av hörselkvalitén. Bolaget grundades ursprungligen under 1904 och har sitt huvudkontor i Smörum.
2022-03-25 13:25:34

25.3.2022 13:25:32 CET | Demant A/S | Investor News

Investor news                                                                                         25 March 2022

Disclosure of historical quarterly figures

 

In response to growing complexity, Demant has over the last years increased transparency and financial disclosures on its business areas and segments. To continue this journey, and as previously announced, we will, beginning from the next Interim Management Statement to be published on 3 May 2022, report quarterly revenue and quarterly growth rates by business area, by segment and for the Group combined. This will also enable easier comparison to peers going forward.

 

For modelling purposes, we have attached historical quarterly revenue numbers for 2020 and 2021 by business area, by segment and for the Group as well as growth rates for 2021 broken down into organic growth, acquisitive growth and exchange rate effects. All reported figures are based on adjusted numbers.

 

Going forward, the Group’s interim management statements will include revenue numbers as well as growth rates relating to the most recent quarter split by organic growth, acquisitive growth and exchange rate effects. Interim reports and annual reports will include the same financial details as previously but will furthermore include revenue as well as growth rates for Q2 and Q4, respectively.

 

Further information:

Søren Nielsen, President & CEO

Phone +45 3917 7300

www.demant.com

Other contacts:

René Schneider, CFO

Mathias Holten Møller, Head of Investor Relations

Peter Pudselykke, Investor Relations Officer

Trine Kromann-Mikkelsen, VP Corporate Communication and Relations

 

 

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments